-
Total per-test unit costs during the experiment, weighted to account for actu...
Total per-test unit costs during the experiment, weighted to account for actual different unit costs by workloads, and costs associated with overtime work and laboratory... -
Model-generated clinical and economic outcomes of TB diagnostic strategies.
Model-generated clinical and economic outcomes of TB diagnostic strategies. -
r37980778c78--1971b31a42ad41c69095b2a56ec3f903
ObjectiveTo compare the population-level impact of two World Health Organization-endorsed strategies for improving the diagnosis of tuberculosis (TB): same-day microscopy and... -
r37980778c78--58e0c653f9c4e77f27f0aff01998b184
Diagnostic accuracy of smear and Xpert MTB/RIF among the MGIT and/or LJ culture positive (n = 328) tuberculosis participants. -
r37980778c78--0c629b719175aee464fd99b1ebe72354
Cumulative Ten-Year Projected Burden of TB (2013–2022) in an African Area with a 2003 Population of 10 Million Adults. -
Temporal trends in TB testing in the smear/culture and Xpert<sup>®</sup> base...
Temporal trends in TB testing in the smear/culture and Xpert® based algorithms. -
Optimal strategy according to the willingness-to-pay threshold (US$/QALYs) in...
Optimal strategy according to the willingness-to-pay threshold (US$/QALYs) in one way sensitivity analysis. -
r37980778c78--f80745d71345739fd2a12be3e6610385
Clinical characteristics of patients with false positivity in either real time TB PCR or Xpert MTB/RIF assay. -
Diagnostic performance of GeneXpert against culture and smear as the referenc...
Diagnostic performance of GeneXpert against culture and smear as the reference standard. -
r37980778c78--1a50b1195c2b88bacd1958513f9ee5d2
Characteristics of patients with NTM or MTB positive culture treated with an anti-TB treatment. -
r37980778c78--7638156b61f6261ffeb45065713c3c1a
Differences in yield of Xpert MTB/RIF assay test by sample or category of sample. -
Diagnostic performance of GeneXpert among 1782 study participants, stratified...
Diagnostic performance of GeneXpert among 1782 study participants, stratified by sputum quality characteristics. -
r37980778c78--6632755a6d896a28a1b14221f4cf1a0f
Xpert MTB/RIF implementation of results at laboratory and POC in Botswana, October 2012 to November 2014. -
A. Drug resistance pattern of first-line anti-TB drugs among culture positive...
A. Drug resistance pattern of first-line anti-TB drugs among culture positive TB patients (n = 87) in the Benishangul Gumuz region and its surroundings, Northwest Ethiopia,... -
r37980778c78--649c9d424af4217f9d3780ca3ecdb18a
Sensitivity and specificity of Xpert and clinical judgment, relative to sputum culture. -
Clinician-attributed causes of death in participants with HIV-associated tube...
Clinician-attributed causes of death in participants with HIV-associated tuberculosis.
